Sucrose-Formulated Recombinant Factor VIII Dosing Flexibility in Prophylaxis Regimens: Experience from Postmarketing Surveillance Studies

por Humphries, Thomas J., Rauchensteiner, Stephan, Tückmantel, Claudia, Pieper, Alexander, Maas Enriquez, Monika, Mathew, Prasad
Publicado 2015

Efficacy and Treatment Burden of Intravitreal Aflibercept Versus Intravitreal Ranibizumab Treat-and-Extend Regimens at 2 Years: Network Meta-Analysis Incorporating Individual Patie...

por Ohji, Masahito, Lanzetta, Paolo, Korobelnik, Jean-Francois, Wojciechowski, Piotr, Taieb, Vanessa, Deschaseaux, Celine, Janer, Daniel, Tuckmantel, Claudia
Publicado 2020

A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS)

por Stefanickova, Jana, Cunha‐Vaz, Jose, Ulbig, Michael, Pearce, Ian, Fernández‐Vega Sanz, Alvaro, Theodossiadis, Panagiotis, Kodjikian, Laurent, Izmailov, Alexander, Muston, Dominic, Vassilev, Zdravko, Lamotte, Benedicte, Tückmantel, Claudia, Friedl, Sabine, Altemark, Andreas, Schwarz, Hans‐Jörg, Katz, Todd
Publicado 2018